Cell & Gene Therapies: A Regulatory Update
Related Insights
Blog
Studying multiple versions of a cellular or gene therapy product in an early-phase clinical trial
Nov 19, 2021
Blog
CAR-T product development: an assessment of FDA’s final guidance for industry
Feb 27, 2024
Podcast
Rare endpoints: Delivering on unmet patient needs
May 7, 2024
Report
New Medicines, Novel Insights: Accelerating development of cell and gene therapies
May 22, 2023
Blog
Making cell and gene therapy more accessible in the treatment of solid tumors
Jun 4, 2024
Podcast
CAR-T boxed warnings: What comes next?
Mar 6, 2024
Playbook
Mitigating risk, protecting potential: Practical strategies that position cell and gene therapy development for success
Mar 28, 2023
Blog
CAR-T boxed warnings: regulatory precedents and opportunities
Feb 9, 2024
Article
Three ways to improve your chances that insurers will pay for a new CGT
Feb 18, 2021
Whitepaper
The Chinese Pharmaceutical Market: Size, R&D, Regulations, Market Access and Innovations
Mar 9, 2023
Whitepaper
How to prepare for Policy 0070: Challenges and opportunities for clinical data publication in the EU
Jun 28, 2023
Webinar
How to navigate China’s regulatory environment
Feb 15, 2023
Related Insights
Blog
Studying multiple versions of a cellular or gene therapy product in an early-phase clinical trial
Nov 19, 2021
Blog
CAR-T product development: an assessment of FDA’s final guidance for industry
Feb 27, 2024
Podcast
Rare endpoints: Delivering on unmet patient needs
May 7, 2024
Report
New Medicines, Novel Insights: Accelerating development of cell and gene therapies
May 22, 2023
Blog
Making cell and gene therapy more accessible in the treatment of solid tumors
Jun 4, 2024
Podcast
CAR-T boxed warnings: What comes next?
Mar 6, 2024
Playbook
Mitigating risk, protecting potential: Practical strategies that position cell and gene therapy development for success
Mar 28, 2023
Blog
CAR-T boxed warnings: regulatory precedents and opportunities
Feb 9, 2024
Article
Three ways to improve your chances that insurers will pay for a new CGT
Feb 18, 2021
Whitepaper
The Chinese Pharmaceutical Market: Size, R&D, Regulations, Market Access and Innovations
Mar 9, 2023
Whitepaper
How to prepare for Policy 0070: Challenges and opportunities for clinical data publication in the EU
Jun 28, 2023
Webinar
How to navigate China’s regulatory environment
Feb 15, 2023